10X GENOMICS INC-CLASS A (TXG) Stock Cash Flow
NASDAQ:TXG - Nasdaq - US88025U1097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -157.04M | -182.63M | -255.10M | -166.00M | -58.22M | |||
| Depreciation Amortization | 34.71M | 35.88M | 35.51M | 25.37M | 21.12M | |||
| Change In Working Capital | 35.83M | 1.25M | 17.34M | -39.42M | -87.45M | |||
| Interest Paid | N/A | 0.00 | 436.00K | 840.00K | 1.22M | |||
| Taxes Paid | 5.14M | 5.64M | 4.93M | 3.93M | 8.66M | |||
| Other non cash items | 143.24M | 152.16M | 187.05M | 146.44M | 103.18M | |||
| OPERATING CASH FLOW | 56.74M | 6.66M | -15.20M | -33.61M | -21.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -12.38M | -13.39M | -49.52M | -131.66M | -101.28M | |||
| Other Investing Activity | -32.78M | -19.24M | 183.02M | -219.23M | -5.45M | |||
| INVESTING CASH FLOW | -45.16M | -32.63M | 133.49M | -350.89M | -106.73M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 9.70M | 10.91M | 19.48M | 21.23M | 40.33M | |||
| Other Financing Activity | N/A | 0.00 | -5.81M | -5.41M | -5.03M | |||
| FINANCING CASH FLOW | 9.70M | 10.91M | 13.67M | 15.82M | 35.30M | |||
| Exchange Rate Effect | -2.00K | -164.00K | -33.00K | -40.00K | 230.00K | |||
| CHANGE IN CASH | 21.28M | -15.22M | 131.93M | -368.72M | -92.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 56.74M | 6.66M | -15.20M | -33.61M | -21.37M | |||
| Capital Expenditure | -12.38M | -13.39M | -49.52M | -131.66M | -101.28M | |||
| FREE CASH FLOW | 44.36M | -6.73M | -64.72M | -165.27M | -122.65M | |||
All data in USD